Litcius/Paper detail

A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer

Huifang Zong, Xi Li, Lei Han, Lei Wang, Junjun Liu, Yali Yue, Jie Chen, Yong Ke, Hua Jiang, Yueqing Xie, Baohong Zhang, Jianwei Zhu

2024Acta Pharmacologica Sinica30 citationsDOIOpen Access PDF

Topics & Concepts

InternalizationAntibody-drug conjugateBreast cancerCancer researchMedicineIn vitroCancerConjugateAntibodyImmunotherapyCancer cellCancer immunotherapyPharmacologyMonoclonal antibodyChemistryImmunologyInternal medicineReceptorBiochemistryMathematicsMathematical analysisMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer ResearchGlycosylation and Glycoproteins Research
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer | Litcius